Oxaliplatin-induced lung fibrosis.

Indian J Med Paediatr Oncol

Departments of Chest Medicine, P.D. Hinduja Hospital, Veer Savarkar Marg, Mahim (W), Mumbai, India.

Published: July 2009

Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930291PMC
http://dx.doi.org/10.4103/0971-5851.64259DOI Listing

Publication Analysis

Top Keywords

pulmonary fibrosis
8
oxaliplatin-induced lung
4
lung fibrosis
4
fibrosis oxaliplatin
4
oxaliplatin approved
4
approved adjuvant
4
adjuvant treatment
4
treatment stage
4
stage iii
4
iii colorectal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!